Skip to main content

Oculis Holding AG

OCS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001953530

No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.

Other share classesOCSAW

Holders of 5% or more of OCS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oculis Holding AG, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of OCS
HolderLatest formStakeChangeFirst filedLatest filingFiling
LSP 7 Cooperative UA13G/A11.80%6.95M shares−2.00 ppfrom 13.80%Feb 12, 20252 filingsApr 29, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Oculis Holding AG, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on OCS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 29, 20264:30 PM ETLSP 7 Cooperative UAand 1 other13G/A11.80%6.95M shares−2.00 ppfrom 13.80%Mar 31, 2026SEC
Mar 27, 20266:30 AM ETBVCF IV, L.P.and 3 others13G/A4.14%2.44M shares−0.91 ppfrom 5.05%Below 5%Feb 13, 2026SEC
Nov 14, 20254:30 PM ETPivotal bioVenture Partners Fund I, L.P.and 9 others13G/A4.90%2.82M shares–Below 5%Sep 30, 2025SEC
Feb 12, 20254:30 PM ETLSP 7 Cooperative UAand 1 other13G/A13.80%5.75M shares–Dec 31, 2024SEC
Feb 11, 20256:52 AM ETBVCF IV, L.P.and 3 others13G/A5.05%2.19M shares–Nov 27, 2024SEC
Jan 3, 20254:45 PM ETBrunnur vaxtarsjodur slhf13G/A0.00%0 shares–Below 5%Dec 30, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Oculis Holding AG shares.

No Form 144 notices for Oculis Holding AG are on file.